US-China Trade Talks: Down to the Wire
ADDED:
15 February 2019
PREPARED BY:
SHARE:
With just two weeks left until the trade truce deadline, will we finally see the US and China come around the negotiation table to strike up a deal and end a bitter trade conflict that has lasted over a year? In the following interview Huang Juin Hao, Senior Portfolio Manager shares the possible scenarios of the trade talks and market implications.

1) Trade negotiations between US and China are currently ongoing, but the 90-day truce period is set to end on 1 March 2019. What are your expectations of the talks and possible outcomes?
Our expectations have shifted. Towards the end of 2018, the market was expecting higher odds of an escalation or widening of trade tariffs against China. This was in part, due to the extremely short time period available for negotiations due to US Christmas holidays in December’18 and China’s Chinese New Year holidays in February’19.

However, the market has since moved their expectations towards a higher probability of a neutral or positive outcome for trade talks after more conciliatory signals from both China and US.

In latest news, US President Donald Trump has expressed willingness to extend the March 1st deadline, while Chinese President Xi Jinping and Vice Premier Liu He is reportedly scheduled to meet with key members of the US trade delegation including US Trade Representative Robert Lighthizer and US Treasury Secretary Steven Mnuchin in Beijing this Friday. We believe the meeting between the top trade envoys signals goodwill and firm efforts to come to a resolution that would be agreeable to both sides.

We are currently leaning towards a base case that sees the status quo remain (no further escalation or de- escalation of the current 25% tariffs imposed on USD$ 250bn worth of goods), and one where it would allow for the deadline to be extended and for talks to be stretched out towards the end of 2019.

2) What are the remaining issues or barriers that could scupper negotiations and prevent a lasting trade deal agreement from being brokered?
The list of demands by US on China broadly fall into several issues including a more balanced and fairer trade as well as technology transfer and intellectual property rights (see more in Table 1).


These can be thought of and placed into 3 categories – the first category is where China is willing to compromise, the second category where China is willing to negotiate and the third category is where China is not willing nor able to negotiate as these issues centre around national security or national ambitions.

The first 2 categories are relatively low- hanging fruits that can be negotiated easily, as seen recently with China pledging to narrow its trade surplus with the US by purchasing more US goods or removing barriers of entry into its domestic market in its auto and finance sector.

We believe the key barrier to a lasting trade agreement is that roughly a third of US demands on China falls into the 3rd category that are non-negotiable.

This could mean China abandoning its ‘Made in China 2025’ goals and being forced to cede its technological advancement ambitions. Any deal resulting in China compromising on this category would certainly be bad optics for President Xi Jinping and the ruling Communist Party by coming across weak and hurt the party politically.

3) We’ve seen EMs perform strongly at the start of the year on the back of a weaker US dollar and Fed turning more dovish. Do you think there are more legs to the current rally once this trade overhang is removed?
Should the US-China trade dispute remain status quo or even improve, the market will have removed one point of uncertainty from the overall global growth outlook. However there are still other points of uncertainty that remain on the horizon clouding the outlook on global growth, such as the US growth momentum, global liquidity tightening, as well as political issues in Europe and the Middle-East.

4) We’ve seen China announced a slew of easing measures to prop-up the market as growth cools domestically. What is your outlook on growth for China and will these stimulus measures be effective?
Currently, the market expects that China’s GDP will grow at a slower pace than in 2018. Thus far the total effect of the announced stimulus measures when compared to those taken during 2015 and 2016 (e.g. reserve requirement ratio (RRR) cuts, special bond issuance, as well as the pace of local government debt issuance and swap), have been roughly on the same magnitude as in 2015/2016.

In 2015, China also had the tailwind of interest rate cuts and the size of the economy was much smaller and the fiscal multiplier effect of stimulus, larger. While details of more possible stimulus measures are in the pipeline and expected to be announced soon (value-added tax (VAT) cuts, stimulus measures for home appliances and autos), we should expect the Chinese authorities to abide by Xi’s emphasis on growth quality rather than speed, hence we do expect growth to continue to soften from 2018.

Table 2: China Easing Cycle Unfolding

5) Beyond the US-China trade conflict, what other factors/key events that you are keeping an eye that could impact the performance of Chinese equities? Are valuations also looking attractive now post sell-off?
A key event we are watching out for in China is the outcome of the 2 sessions meeting in early March [both the Chinese People's Political Consultative Conference (CPPCC) and the National People's Congress (NPC)], which will see the country’s top advisory body and top legislative body meet to chart the course ahead and to approve work reports for 2019. We are waiting to see if further details on stimulus measures will also be announced then.

In a challenged year, the Shanghai Composite Index and MSCI China Index fell 20-24% in 2018. The market has since rebounded by some 9-12% YTD. Valuations are now below or hovering at long-term average levels.

Global funds which were cautious and largely under weighted in China are beginning to short-cover and flows are beginning to move back into Chinese equities. A trade status-quo outcome and possible further stimulus then could offer an attractive risk-reward for those sectors which are relatively insulated from trade and for domestic structural growth sectors.
Hello, I'm Nadia. How may I help you?
Talk to Nadia
Close
Not sure what to ask? Try these.
  1. I forgot my i-Access password.
  2. How to perform redemption?
  3. What is the minimum amount to open an investment account?
  4. Checklist for deceased redemption.
  5. What is the best fund for me?
<  Slide to cancel
I'm listening ...
Click to stop recording
TENG CHEE WAI

Managing Director
Teng Chee Wai is the founder of Affin Hwang Asset Management Berhad (Affin Hwang AM). Over the past decade, he has built the Company to be the fastest growing and only independent investment management house in Malaysia’s top three, with an excess of RM47 billion in assets under management as at 31 December 2018.​

​In his capacity as Managing Director / Executive Director, Teng manages the overall business and strategic direction as well as the management of the investment team. His hands-on approach sees him actively involved in investments, product development and marketing. Teng’s critical leadership and regular participation in reviewing and assessing strategies and performance has been pivotal in allowing the Company to successfully navigate the economically turbulent decade.

Teng’s investment management experience spans more than 20 years, and his key area of expertise is in managing absolute return mandates for insurance assets and investment-linked funds in both Singapore and Malaysia. Prior to his current appointments, he was the Assistant General Manager (Investment) of Overseas Assurance Corporation (OAC) and was responsible for the investment function of the Group Overseas Assurance Corporation Ltd.​

​Teng began his career in the financial industry as an Investment Manager with NTUC Income, Singapore. He is a Bachelor of Science graduate from the National University of Singapore and has a Post-Graduate Diploma in Actuarial Studies from City University in London.
Ooops!
Generic Popup